Report copyright - Roche Investor Presentation - Half-Year Results - Appendix · RG-No Roche Genentech managed CHU Chugai managed RG105 MabThera is branded as Rituxan in US and Japan RG1569 Actemra
Please pass captcha verification before submit form
Please pass captcha verification before submit form